Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert PanelThe oncologist (Dayton, Ohio), 2022-09, Vol.27 (9), p.722-731 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press. ;COPYRIGHT 2022 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press. 2022 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac101 ;PMID: 35704278Full text available |
|
2 |
Material Type: Article
|
Breast Awareness, Self‐Reported Abnormalities, and Breast Cancer in Rural Ethiopia: A Survey of 7,573 Women and Predictions of the National BurdenThe oncologist (Dayton, Ohio), 2021-06, Vol.26 (6), p.e1009-e1017 [Peer Reviewed Journal]2021 The Authors. published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13737 ;PMID: 33650727Full text available |
|
3 |
Material Type: Article
|
Affinity proteomics within rare diseases: a BIO‐NMD study for blood biomarkers of muscular dystrophiesEMBO molecular medicine, 2014-07, Vol.6 (7), p.918-936 [Peer Reviewed Journal]2014 The Authors. Published under the terms of the CC BY 4.0 license ;2014 The Authors. Published under the terms of the CC BY 4.0 license. ;COPYRIGHT 2014 John Wiley & Sons, Inc. ;2014. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 The Authors. Published under the terms of the CC BY 4.0 license 2014 ;ISSN: 1757-4676 ;ISSN: 1757-4684 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201303724 ;PMID: 24920607Full text available |
|
4 |
Material Type: Article
|
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell CarcinomaThe oncologist (Dayton, Ohio), 2023-03, Vol.28 (3), p.220-229 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press. 2022 ;The Author(s) 2022. Published by Oxford University Press. ;COPYRIGHT 2023 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac249 ;PMID: 36562592Full text available |
|
5 |
Material Type: Article
|
Rethinking the nonprofit foundation: an emerging niche in the rare disease ecosystemEMBO molecular medicine, 2017-09, Vol.9 (9), p.1179-1182 [Peer Reviewed Journal]2017 Children's Tumor Foundation. Published under the terms of the CC BY 4.0 license ;COPYRIGHT 2017 John Wiley & Sons, Inc. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201708203 ;PMID: 28743783Full text available |
|
6 |
Material Type: Article
|
The awesome lysosomeEMBO molecular medicine, 2016-02, Vol.8 (2), p.73-76 [Peer Reviewed Journal]2015 The Author. Published under the terms of the CC BY 4.0 license ;COPYRIGHT 2016 John Wiley & Sons, Inc. ;2016. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201505966 ;PMID: 26787653Full text available |
|
7 |
Material Type: Article
|
The location of splenic NKT cells favours their rapid activation by blood-borne antigenThe EMBO journal, 2012-05, Vol.31 (10), p.2378-2390 [Peer Reviewed Journal]Copyright © 2012 European Molecular Biology Organization ;Copyright © 2012, European Molecular Biology Organization 2012 European Molecular Biology Organization ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.1038/emboj.2012.87 ;PMID: 22505026 ;CODEN: EMJODGFull text available |
|
8 |
Material Type: Article
|
Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II TrialThe oncologist (Dayton, Ohio), 2023-05, Vol.28 (5), p.e254-e262 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press. 2023 ;The Author(s) 2023. Published by Oxford University Press. ;COPYRIGHT 2023 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac261 ;PMID: 36648325Full text available |
|
9 |
Material Type: Article
|
Utility of Low-Dose Duvelisib for Advanced Mycosis Fungoides: A Single-Institution StudyThe oncologist (Dayton, Ohio), 2024-03, Vol.29 (3), p.272 [Peer Reviewed Journal]COPYRIGHT 2024 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/onoolo/oyad345Full text available |
|
10 |
Material Type: Article
|
Calcineurin–NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapyEMBO molecular medicine, 2017-08, Vol.9 (8), p.990-999 [Peer Reviewed Journal]2017 The Authors. Published under the terms of the CC BY 4.0 license ;2017 The Authors. Published under the terms of the CC BY 4.0 license. ;COPYRIGHT 2017 John Wiley & Sons, Inc. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201707698 ;PMID: 28606994Full text available |
|
11 |
Material Type: Article
|
Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight LossThe oncologist (Dayton, Ohio), 2021-06, Vol.26 (6), p.e963-e970 [Peer Reviewed Journal]2021 The Authors. published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13774 ;PMID: 33818860Full text available |
|
12 |
Material Type: Article
|
The Use of Natural Language Processing to Assess Social Support in Patients With Advanced CancerThe oncologist (Dayton, Ohio), 2023-02, Vol.28 (2), p.165-171 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press. ;COPYRIGHT 2023 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press. 2022 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac238 ;PMID: 36427022Full text available |
|
13 |
Material Type: Article
|
Diagnostic host gene signature for distinguishing enteric fever from other febrile diseasesEMBO molecular medicine, 2019-10, Vol.11 (10), p.e10431-n/a [Peer Reviewed Journal]2019 The Authors. Published under the terms of the CC BY 4.0 license ;2019 The Authors. Published under the terms of the CC BY 4.0 license. ;COPYRIGHT 2019 John Wiley & Sons, Inc. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201910431 ;PMID: 31468702Full text available |
|
14 |
Material Type: Article
|
Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liverEMBO molecular medicine, 2017-06, Vol.9 (6), p.816-834 [Peer Reviewed Journal]2017 The Authors. Published under the terms of the CC BY 4.0 license ;2017 The Authors. Published under the terms of the CC BY 4.0 license. ;COPYRIGHT 2017 John Wiley & Sons, Inc. ;2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.201607006 ;PMID: 28360091Full text available |
|
15 |
Material Type: Article
|
Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic CancerThe oncologist (Dayton, Ohio), 2021-04, Vol.26 (4), p.290-e545 [Peer Reviewed Journal]AlphaMed Press; the data published online to support this summary are the property of the authors. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13631 ;PMID: 33296125Full text available |
|
16 |
Material Type: Article
|
Safety and Efficacy of Cetuximab‐Based Salvage Chemotherapy After Checkpoint Inhibitors in Head and Neck CancerThe oncologist (Dayton, Ohio), 2021-06, Vol.26 (6), p.e1018-e1035 [Peer Reviewed Journal]2021 AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13754 ;PMID: 33751752Full text available |
|
17 |
Material Type: Article
|
Patient Blood Type Is Associated With Response to Immune Checkpoint Blockade in Metastatic CancerThe oncologist (Dayton, Ohio), 2022-09, Vol.27 (9), p.e739-e747 [Peer Reviewed Journal]COPYRIGHT 2022 Oxford University Press ;The Author(s) 2022. Published by Oxford University Press. 2022 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyac128 ;PMID: 35816018Full text available |
|
18 |
Material Type: Article
|
The Use of Wearable Devices in Oncology Patients: A Systematic ReviewThe oncologist (Dayton, Ohio), 2024-04, Vol.29 (4), p.e419-e430 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press. ;COPYRIGHT 2024 Oxford University Press ;The Author(s) 2023. Published by Oxford University Press. 2023 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad305 ;PMID: 37971410Full text available |
|
19 |
Material Type: Article
|
A Phase II Study of Apatinib in Patients with Chemotherapy‐Refractory Esophageal Squamous Cell Carcinoma (ESO‐Shanghai 11)The oncologist (Dayton, Ohio), 2021-06, Vol.26 (6), p.e925-e935 [Peer Reviewed Journal]2021 The Authors. published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;2021 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press. ;COPYRIGHT 2021 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1002/onco.13668 ;PMID: 33393167Full text available |
|
20 |
Material Type: Article
|
miR‐9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCCEMBO molecular medicine, 2021-07, Vol.13 (7), p.n/a [Peer Reviewed Journal]2021 The Authors. Published under the terms of the CC BY 4.0 license ;COPYRIGHT 2021 John Wiley & Sons, Inc. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1757-4676 ;EISSN: 1757-4684 ;DOI: 10.15252/emmm.202012872 ;PMID: 34062049Full text available |